The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 62 sources its claims cite is checked for support yet.
Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters
Open accessAbstract
Background: The cannabinoid receptor 2 (CB 2 ) is involved in regulating immune responses, yet its specific function in microglia remains poorly defined. This study aimed to generate and validate a microglia-specific, inducible CB 2 knockout mouse model incorporating reporter genes to enable precise detection of CB 2 expression and CB 2 knockout. Methods: A novel floxed CB 2 mouse line was generated, incorporating GFP and tdTomato reporter genes driven by the Cnr2 promoter to indicate CB 2 expression and CB 2 knockout, respectively. This line was crossed with Cx3cr1 or Tmem119 tamoxifen-inducible Cre lines to achieve macrophage- or microglia-specific CB 2 knockout, respectively. Behavioural testing, in vitro assays, sequencing and in vivo immunofluorescence were used to assess the efficiency and specificity of CB 2 knockout as well as potential off-target effects. Results: The floxed allele did not alter breeding or motor behaviour in mice, nor CB 2 function. CB 2 expression, indicated by GFP, followed expected patterns across tissues and conditions. Sequencing revealed both DNA and RNA of the floxed allele was as anticipated. Tamoxifen-induced Cre activity successfully initiated tdTomato expression exclusively in microglia of tamoxifen treated, Cre positive mice, validating the specificity and inducibility of CB 2 knockout. Microglial tdTomato expression confirmed successful CB 2 knockout in 9.3% of TmemCB 2 and 91.7% of Cx3CB 2 microglia. Peripheral tdTomato expression persisted beyond 3 weeks post-tamoxifen in Cx3CB 2 mice but was minimal in TmemCB 2 mice. Conclusion: This novel microglia-specific, inducible CB 2 knockout model is the first to combine a floxed CB 2 allele with reporter genes, an essential advancement given the lack of reliable CB 2 antibodies. The findings demonstrate the model’s specificity and effectiveness, while highlighting important considerations regarding Cre-mediated effects and recombination specificity. Furthermore, the floxed mouse can be crossed with any Cre line to study CB 2 expression and function in various tissues. This model provides a powerful platform for advancing understanding of CB 2 roles in microglia and supports future exploration of CB 2 -targeted therapeutic strategies.
Checked 2026-11-19 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
The authors generated and validated a novel floxed Cnr2 (CB2) mouse line in which GFP reports CB2 promoter activity and a Cre-dependent FLEx-switched tdTomato permanently marks cells that have undergone CB2 knockout. Crossed to Cx3cr1- or Tmem119-driven tamoxifen-inducible Cre lines, the model produced microglia-specific recombination without altering breeding, motor behaviour, or CB2 signalling, though peripheral recombination persisted beyond 3 weeks in the Cx3CB2 line.
Key findings
- The floxed allele was functionally neutral: no differences from BL6 controls in litter size (F(3, 196) = 1.31, p = 0.27), mortality (KW(4, 200) = 3.79, p = 0.28), sex ratio (F(3, 192) = 0.094, p = 0.96), open-field distance (t(11) = 0.670, p = 0.516), or rotarod latency to fall (t(11) = 0.346, p = 0.736). Hu308-induced cAMP inhibition was equivalent across CB2flx, Cx3CB2, and BL6 in microglia (F(2,28) = 0.027, p = 0.973) and astrocytes (F(2,32) = 0.432, p = 0.653).
- GFP expression matched expected CB2 distribution: minimal in naive CNS, strong in spleen white pulp, and markedly upregulated in the CNS after intrastriatal LPS.
- Tamoxifen-induced tdTomato was microglia-specific and Cre-dependent, confirming CB2 knockout in 9.3% of TmemCB2 microglia (F(3, 8) = 18.23, p = 0.0006) and 91.7% of Cx3CB2 microglia; 94.3% of tdT signal colocalized with Iba1 in TmemCB2 mice, and >92% in Cx3CB2 mice, with no significant differences among the three tamoxifen protocols (F(2, 7) = 4.07, p = 0.067).
- Peripheral tdT persisted in Cx3CB2 spleens beyond 3 weeks post-tamoxifen, contradicting the assumption that this washout yields microglia-restricted recombination; TmemCB2 spleens showed only rare tdT.
Methods
- Generation of the C57BL/6-Cnr2 tm1(GFP,tdTomato)BViss/J (CB2flx) line: the entire Cnr2 coding region flanked by loxP sites, with GFP in sense orientation and a tdTomato cassette in inverse orientation flanked by lox2272 sites (FLEx switch), both under the Cnr2 promoter; crossed to Cx3cr1-Cre/ERT2 (Cx3CB2) and Tmem119-Cre/ERT2 (TmemCB2) lines.
- Validation battery: DNA and mRNA sequencing (OzGene; Garvan Genetics Core), breeding outcome analysis (50 litters per strain), open-field and accelerating rotarod testing, primary glial cAMP assays with the CB2 agonist Hu308, and immunofluorescence colocalization (GFP, tdT, Iba1, CD68, GFAP, NeuN) quantified in FIJI with the Colocalization Object Counter plugin.
- Tamoxifen regimens compared: 150 mg/kg every other day ×4, 100 mg/kg daily ×8, or 100 mg/kg twice daily ×10; tissue collected 3 weeks after the final injection. Neuroinflammation was induced by stereotaxic intrastriatal LPS (5 mg/mL, two 1 µL injections) with histology 15 days post-surgery. Statistics used Prism 10 with ANOVA and Tukey's, Dunnett's, Dunn's, or Šídák's post hoc tests.
Limitations
- Stated: tdT is only expressed when the Cnr2 promoter is active, so because basal CNS CB2 expression is very low, most knockout cells would not be expected to express tdT — the authors note DNA-based methods such as in situ hybridisation are needed for definitive KO efficiency confirmation.
- Stated: in Cx3CB2 Cre/+ microglia, overlapping GFP and YFP emission spectra could not be distinguished, preventing direct assessment of CB2-driven GFP in those cells; a 510 bp stretch of the 5′ homology arm yielded incomplete DNA sequencing data due to poor trace quality (though the low-quality region showed 100% identity to the predicted sequence).
- Stated: tdT expression exceeded GFP expression in controls despite both being driven by the Cnr2 promoter, which the authors attribute speculatively to Cre toxicity — a hypothesis they explicitly say requires further research; they also note Tmem119 is downregulated in activated microglia and that 3 weeks is insufficient for peripheral clearance in the Cx3CB2 line, requiring a time-course study. Evident from the text: colocalization quantification used small group sizes (N = 3–4 per group).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
0 Valid · 3 Not valid · 31 Not checked · 134 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no significant difference between groups for litter size (F (3, 196) = 1.31, p = 0.27; Figure 2A)”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“mortality rate (KW(4, 200) = 3.79, p = 0.28; Figure 2B)”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conversely, tdT was detected in Cx3CB2 Cre/+ spleens 1-week post-Tam, as anticipated (Supplementary Figure S6B).”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Tam induces microglial specific tdT expression in Cx3CB2 mice
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Microglial tdTomato expression confirmed successful CB2 knockout in 9.3% of TmemCB2 and 91.7% of Cx3CB2 microglia.”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Abstract > Results
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the absence of Cre recombinase, CB2 and GFP are expressed under the control of the Cnr2 promoter.”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Methods > Animals
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
120 more claims
Create a free account to see all 168 claims and to verify the 51 references still open.
- The quote only partly states this claim. 1
- It may state two separate claims as one. 25
- Probably not a substantial claim. 21
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(3, 196) = 1.31reported p = .27 · recomputed p = .272
“F (3, 196) = 1.31, p = .27”
- ConsistentF(3, 192) = 0.094reported p = .96 · recomputed p = .963
“F (3, 192) = 0.094, p = .96”
- Consistentt(11) = 0.67reported p = .516 · recomputed p = .517
“t (11) = 0.670, p = .516”
- Consistentt(11) = 0.421reported p = .682 · recomputed p = .682
“t (11) = 0.421, p = .682”
- Consistentt(11) = 1.138reported p = .279 · recomputed p = .279
“t (11) = 1.138, p = .279”
8 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Discussion
“Importantly, tdT expression was exclusively observed in microglia of Cre/+ mice following Tam administration, validating the inducibility and specificity of the Cre-lox system.”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Tamoxifen induced reporter gene expression in the TmemCB2 line
“However, rare tdT expression was detected in the spleen of Tam-treated TmemCB2 Cre/+ mice (Figures 9C,D), though at significantly lower levels than in Cx3CB2 mice.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
“mortality rate (KW(4, 200) = 3.79, p = 0.28; Figure 2B)”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
“(B) Proportion of litter mortality between birth and weaning. One-way ANOVA, Dunnett’s post hoc test.”
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Microglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,818
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525
Structure and function of the immune system in the spleen
Lewis, S. M., Williams, A., & Eisenbarth, S. C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6085 · Cited by 1,301
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
Self-Renewing Resident Cardiac Macrophages Limit Adverse Remodeling Following Myocardial Infarction
Dick, S. A., Macklin, J. A., Nejat, S., Momen, A., Clemente-Casares, X., Althagafi, M. G., Chen, J., Kantores, C., Hosseinzadeh, S., Aronoff, L., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0272-2 · Cited by 883
Microglia: Immune and non-immune functions
Borst, K., Dumas, A. A., & Prinz, M. (2021) · Immunity · doi:10.1016/j.immuni.2021.09.014 · Cited by 804
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 619
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Chen, X., Firulyova, M., Manis, M., Herz, J., Smirnov, I., Aladyeva, E., Wang, C., Bao, X., Finn, M. B., Hu, H., et al. (2023) · Nature · doi:10.1038/s41586-023-05788-0 · Cited by 609
Joshi, A. U., Minhas, P. S., Liddelow, S. A., Haileselassie, B., Andreasson, K. I., Dorn, G. W., & Mochly-Rosen, D. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0486-0 · Cited by 571
Walker, D. G., & Lue, L.-F. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0139-9 · Cited by 562
Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner
Willis, E. F., MacDonald, K. P. A., Nguyen, Q. H., Garrido, A. L., Gillespie, E. R., Harley, S. B. R., Bartlett, P. F., Schroder, W. A., Yates, A. G., Anthony, D. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.013 · Cited by 520
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
Shi, Y., Manis, M., Long, J., Wang, K., Sullivan, P. M., Remolina Serrano, J., Hoyle, R., & Holtzman, D. M. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190980 · Cited by 448
Isolation and Culture of Mouse Cortical Astrocytes
Schildge, S., Bohrer, C., Beck, K., & Schachtrup, C. (2013) · Journal of Visualized Experiments · doi:10.3791/50079 · Cited by 434
Skrzypczak-Wiercioch, A., & Sałat, K. (2022) · Molecules · doi:10.3390/molecules27175481 · Cited by 406
Microglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration
Ryan, S. K., Zelic, M., Han, Y., Teeple, E., Chen, L., Sadeghi, M., Shankara, S., Guo, L., Li, C., Pontarelli, F., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01221-3 · Cited by 358
Mizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., & Cardona, A. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100421 · Cited by 346
Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy
Wang, C., Fan, L., Khawaja, R. R., Liu, B., Zhan, L., Kodama, L., Chin, M., Li, Y., Le, D., Zhou, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29552-6 · Cited by 333
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Peng, J., Gu, N., Zhou, L., B Eyo, U., Murugan, M., Gan, W.-B., & Wu, L.-J. (2016) · Nature Communications · doi:10.1038/ncomms12029 · Cited by 300
Microglial phagocytosis of neurons in neurodegeneration, and its regulation
Butler, C. A., Popescu, A. S., Kitchener, E. J. A., Allendorf, D. H., Puigdellívol, M., & Brown, G. C. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15327 · Cited by 295
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
Stempel, A. V., Stumpf, A., Zhang, H.-Y., Özdoğan, T., Pannasch, U., Theis, A.-K., Otte, D.-M., Wojtalla, A., Rácz, I., Ponomarenko, A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.034 · Cited by 292
Microglia and the aging brain: are senescent microglia the key to neurodegeneration?
Angelova, D. M., & Brown, D. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14860 · Cited by 262
Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia
Kaiser, T., & Feng, G. (2019) · eneuro · doi:10.1523/eneuro.0448-18.2019 · Cited by 259
Tmem119-EGFP and Tmem119-CreERT2 transgenic mice for labeling and manipulating microglia
Kaiser, T., & Feng, G. (2019) · doi:10.1101/624825 · Cited by 258
Sobue, A., Komine, O., Hara, Y., Endo, F., Mizoguchi, H., Watanabe, S., Murayama, S., Saito, T., Saido, T. C., Sahara, N., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01099-x · Cited by 253
Martín-Moreno, A. M., Brera, B., Spuch, C., Carro, E., García-García, L., Delgado, M., Pozo, M. A., Innamorato, N. G., Cuadrado, A., & de Ceballos, M. L. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-8 · Cited by 241
The Role of Microglia and Astrocytes in Huntington’s Disease
Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00258 · Cited by 239
How microglia sense and regulate neuronal activity
Umpierre, A. D., & Wu, L. (2021) · Glia · doi:10.1002/glia.23961 · Cited by 237
Zarruk, J. G., Fernández-López, D., García-Yébenes, I., García-Gutiérrez, M. S., Vivancos, J., Nombela, F., Torres, M., Burguete, M. C., Manzanares, J., Lizasoain, I., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.631044 · Cited by 215
Gómez-Gálvez, Y., Palomo-Garo, C., Fernández-Ruiz, J., & García, C. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.017 · Cited by 208
The effects of microglia‐ and astrocyte‐derived factors on neurogenesis in health and disease
Araki, T., Ikegaya, Y., & Koyama, R. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14969 · Cited by 205
Cellular communities reveal trajectories of brain ageing and Alzheimer’s disease
Green, G. S., Fujita, M., Yang, H.-S., Taga, M., Cain, A., McCabe, C., Comandante-Lou, N., White, C. C., Schmidtner, A. K., Zeng, L., et al. (2024) · Nature · doi:10.1038/s41586-024-07871-6 · Cited by 204
CB 2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Aso, E., Juvés, S., Maldonado, R., & Ferrer, I. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130137 · Cited by 203
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
Subbarayan, M. S., Joly-Amado, A., Bickford, P. C., & Nash, K. R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107989 · Cited by 202
Sagredo, O., González, S., Aroyo, I., Pazos, M. R., Benito, C., Lastres‐Becker, I., Romero, J. P., Tolón, R. M., Mechoulam, R., Brouillet, E., et al. (2009) · Glia · doi:10.1002/glia.20838 · Cited by 201
The Endocannabinoid System of Animals
Silver, R. (2019) · Animals · doi:10.3390/ani9090686 · Cited by 196
Onaivi, E. S. (2006) · Neuropsychobiology · doi:10.1159/000100778 · Cited by 191
Bido, S., Muggeo, S., Massimino, L., Marzi, M. J., Giannelli, S. G., Melacini, E., Nannoni, M., Gambarè, D., Bellini, E., Ordazzo, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26519-x · Cited by 190
Dong, Y., D’Mello, C., Pinsky, W., Lozinski, B. M., Kaushik, D. K., Ghorbani, S., Moezzi, D., Brown, D., Melo, F. C., Zandee, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00801-z · Cited by 181
Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration
Ding, X., Wang, J., Huang, M., Chen, Z., Liu, J., Zhang, Q., Zhang, C., Xiang, Y., Zen, K., & Li, L. (2021) · Nature Communications · doi:10.1038/s41467-021-22301-1 · Cited by 180
Young microglia restore amyloid plaque clearance of aged microglia
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.011 · Cited by 171
Lee, J., Kim, D. E., Griffin, P. Y., Sheehan, P. W., Kim, D., Musiek, E. S., & Yoon, S. (2019) · Aging Cell · doi:10.1111/acel.13078 · Cited by 168
Ojha, S., Javed, H., Azimullah, S., & Haque, M. E. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2733-y · Cited by 165
Wang, P. L., Yim, A. K. Y., Kim, K.-W., Avey, D., Czepielewski, R. S., Colonna, M., Milbrandt, J., & Randolph, G. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16355-w · Cited by 160
Liu, Q.-R., Canseco-Alba, A., Zhang, H.-Y., Tagliaferro, P., Chung, M., Dennis, E., Sanabria, B., Schanz, N., Escosteguy-Neto, J. C., Ishiguro, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17796-y · Cited by 147
Tao, L., Liu, Q., Zhang, F., Fu, Y., Zhu, X. D., Weng, X., Han, H., Huang, Y., Suo, Y., Chen, L., et al. (2021) · Light Science & Applications · doi:10.1038/s41377-021-00617-3 · Cited by 146
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 140
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
López, A., Aparicio, N., Pazos, M. R., Grande, M. T., Barreda-Manso, M. A., Benito-Cuesta, I., Vázquez, C., Amores, M., Ruiz-Pérez, G., García-García, E., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1174-9 · Cited by 139
Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 139
Fricker, M., Oliva-Martín, M. J., & Brown, G. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-196 · Cited by 137
Fakhfouri, G., Ahmadiani, A., Rahimian, R., Grolla, A. A., Moradi, F., & Haeri, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.013 · Cited by 128
Braun, M., Khan, Z. T., Khan, M. B., Kumar, M., Ward, A. L., Achyut, B. R., Arbab, A. S., Hess, D. C., Hoda, M. N., Baban, B., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.021 · Cited by 128
Treatment of a genetic brain disease by CNS-wide microglia replacement
Shibuya, Y., Kumar, K. K., Mader, M. M.-D., Yoo, Y., Ayala, L. A., Zhou, M., Mohr, M. A., Neumayer, G., Kumar, I., Yamamoto, R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl9945 · Cited by 126
Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Xia, Y., Zhang, G., Kou, L., Yin, S., Han, C., Hu, J., Wan, F., Sun, Y., Wu, J., Li, Y., et al. (2021) · Brain · doi:10.1093/brain/awab122 · Cited by 123
Chung, Y. C., Shin, W.-H., Baek, J. Y., Cho, E. J., Baik, H. H., Kim, S. R., Won, S.-Y., & Jin, B. K. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.100 · Cited by 119
Paredes, J. M. V., González-Castañeda, R. E., Gertsch, J., Chaparro-Huerta, V., López-Roa, R. I., Vázquez-Valls, E., Beas‐Zárate, C., Camins, A., & Flores-Soto, M. E. (2017) · Pharmaceuticals · doi:10.3390/ph10030060 · Cited by 118
Antignano, I., Liu, Y., Offermann, N., & Capasso, M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04775-y · Cited by 117 · cited 1×
“The endocannabinoid system (ECS), a tightly regulated signalling network present in all animal species, is a key regulator of homeostasis, including immune responses (Di Marzo, 2018; Van et al., 2021; Silver, 2019; Lowe et al., 2021; Antignano et al., 2023; Rakotoarivelo et al., 2024).”
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
Verty, A. N. A., Stefanidis, A., McAinch, A. J., Hryciw, D. H., & Oldfield, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140592 · Cited by 117
NGF steers microglia toward a neuroprotective phenotype
Rizzi, C., Tiberi, A., Giustizieri, M., Marrone, M. C., Gobbo, F., Carucci, N. M., Meli, G., Arisi, I., D’Onofrio, M., Marinelli, S., et al. (2018) · Glia · doi:10.1002/glia.23312 · Cited by 117
TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4.
Gratuze, M., Schlachetzki, J. C. M., D’Oliveira Albanus, R., Jain, N., Novotny, B., Brase, L., Rodriguez, L., Mansel, C., Kipnis, M., O’Brien, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2022.10.022 · Cited by 115
A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer’s disease
Yoo, Y., Neumayer, G., Shibuya, Y., Mader, M. M.-D., & Wernig, M. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.07.006 · Cited by 109
Ultrastructural localization of neuronal brain CB2 cannabinoid receptors
Brusco, A., Tagliaferro, P. A., Saez, T., & Onaivi, E. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.037 · Cited by 109
Endocannabinoid System Components: Overview and Tissue Distribution
Joshi, N., & Onaivi, E. S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-21737-2_1 · Cited by 108
Youssef, D. A., El‐Fayoumi, H. M., & Mahmoud, M. F. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.010 · Cited by 104
Liu, X., Chen, Y., Wang, H., Wei, Y., Yuan, Y., Zhou, Q., Fang, F., Shi, S., Jiang, X., Dong, Y., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.125997 · Cited by 104
Kong, W., Li, H., Tuma, R. F., & Ganea, D. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.11.002 · Cited by 99
Microglial P2Y12 Receptor Regulates Seizure-Induced Neurogenesis and Immature Neuronal Projections
Mo, M., Eyo, U. B., Xie, M., Peng, J., Bosco, D. B., Umpierre, A. D., Zhu, X., Tian, D., Xu, P., & Wu, L. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0487-19.2019 · Cited by 96
The cannabinoid system and microglia in health and disease
Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem-Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 94
Salvadores, N., Moreno‐González, I., Gamez, N., Quiroz, G., Vegas‐Gomez, L., Escandón, M., Jiménez, S., Vitórica, J., Gutiérrez, A., Soto, C. A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01332-9 · Cited by 92
Sahasrabuddhe, V., & Ghosh, H. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110252 · Cited by 91
Microglia protect against age-associated brain pathologies
Munro, D. A. D., Bestard-Cuche, N., McQuaid, C., Chagnot, A., Shabestari, S. K., Chadarevian, J. P., Maheshwari, U., Szymkowiak, S., Morris, K., Mohammad, M., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.018 · Cited by 90
Schmöle, A., Lundt, R., Ternes, S., Albayram, Ö., Ulas, T., Schultze, J. L., Bano, D., Nicotera, P., Alferink, J., & Zimmer, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.019 · Cited by 88
Chadarevian, J. P., Hasselmann, J., Lahian, A., Capocchi, J. K., Escobar, A., Lim, T. E., Le, L., Tu, C., Nguyen, J., Kiani Shabestari, S., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.023 · Cited by 83
The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
Rakotoarivelo, V., Mayer, T. Z., Simard, M., Flamand, N., & Marzo, V. D. (2024) · Molecules · doi:10.3390/molecules29143381 · Cited by 82
Transmembrane protein 119 is neither a specific nor a reliable marker for microglia
Vankriekelsvenne, E., Chrzanowski, U., Manzhula, K., Greiner, T., Wree, A., Hawlitschka, A., Llovera, G., Zhan, J., Joost, S., Schmitz, C., et al. (2022) · Glia · doi:10.1002/glia.24164 · Cited by 81
Endocannabinoid signaling in astrocytes
Eraso‐Pichot, A., Pouvreau, S., Olivera‐Pinto, A., Gomez‐Sotres, P., Skupio, U., & Marsicano, G. (2023) · Glia · doi:10.1002/glia.24246 · Cited by 81
Bedolla, A., Wegman, E., Weed, M., Stevens, M. K., Ware, K., Paranjpe, A., Alkhimovitch, A., Ifergan, I., Taranov, A., Peter, J. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49596-0 · Cited by 81
Rodero, M. P., Marie, Y., Coudert, M., Blondet, E., Mokhtari, K., Rousseau, A., Raoul, W., Carpentier, C., Sennlaub, F., Déterre, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2833 · Cited by 79
Espejo‐Porras, F., García‐Toscano, L., Rodríguez‐Cueto, C., Santos‐García, I., de Lago, E., & Fernández‐Ruíz, J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14216 · Cited by 78
Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis
Andersen, M. S., Bandrés‐Ciga, S., Reynolds, R. H., Hardy, J., Ryten, M., Krohn, L., Gan‐Or, Z., Holtman, I. R., & Pihlstrøm, L. (2021) · Annals of Neurology · doi:10.1002/ana.26032 · Cited by 77
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Yu, S., Reiner, D. J., Shen, H., Wu, K., Liu, Q., & Wang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132487 · Cited by 76
Formation of B and T cell subsets require the cannabinoid receptor CB2
Ziring, D., Wei, B., Velazquez, P., Schrage, M., Buckley, N. E., & Braun, J. (2006) · Immunogenetics · doi:10.1007/s00251-006-0138-x · Cited by 75
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Grabon, W., Rheims, S., Smith, J., Bodennec, J., Belmeguenaï, A., & Bezin, L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105226 · Cited by 74
Wang, W., Li, Y., Ma, F., Sheng, X., Chen, K., Zhuo, R., Wang, C., Zheng, H., Zhang, Y.-W., Bu, G., et al. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.07.011 · Cited by 71
A versatile toolbox for semi-automatic cell-by-cell object-based colocalization analysis
Lunde, A., & Glover, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-75835-7 · Cited by 70
Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
Whiting, Z. M., Yin, J., de la Harpe, S. M., Vernall, A. J., & Grimsey, N. L. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.06.010 · Cited by 70
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation.
Rossi, F., Bellini, G., Luongo, L., Manzo, I., Tolone, S., Tortora, C., Bernardo, M., Grandone, A., Conforti, A., Docimo, L., et al. (2016) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2015-4381 · Cited by 69
Li, C., Shi, J., Wang, B., Li, J., & Jia, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134286 · Cited by 68
Expression and Functions of the CB2 Receptor in Human Leukocytes
Simard, M., Rakotoarivelo, V., Marzo, V. D., & Flamand, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.826400 · Cited by 66
Bedolla, A. M., McKinsey, G. L., Ware, K., Santander, N., Arnold, T. D., & Luo, Y. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113660 · Cited by 65
Tang, J., Chen, Q., Guo, J., Yang, L. M., Tao, Y., Li, L., Miao, H., Feng, H., Chen, Z., & Zhu, G. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9154-x · Cited by 62
Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
Zheng, T., & Zhang, Z. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105094 · Cited by 61
Microglia: Friend and foe in tauopathy
Odfalk, K. F., Bieniek, K. F., & Hopp, S. C. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102306 · Cited by 60
Yang, Z., Liu, B., Yang, L., & Zhang, C. (2019) · Molecules · doi:10.3390/molecules24183207 · Cited by 60
Wang, P., Yang, P., Qian, K., Li, Y., Xu, S., Meng, R., Guo, Q., Cheng, Y., Cao, J., Xu, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121360 · Cited by 58
Microglia-derived extracellular vesicles trigger age-related neurodegeneration upon DNA damage
Arvanitaki, E. S., Goulielmaki, E., Gkirtzimanaki, K., Niotis, G., Tsakani, E., Nenedaki, E., Rouska, I., Kefalogianni, M., Xydias, D., Kalafatakis, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317402121 · Cited by 58
Neuroprotective and Neurotoxic Effects of Glial-Derived Exosomes
Oyarce, K., Cepeda, M. Y., Lagos, R., Garrido, C., Vega-Letter, A. M., García, M. D. L. Á., Luz‐Crawford, P., & Elizondo-Vega, R. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.920686 · Cited by 57
Zhang, H.-Y., Shen, H., Jordan, C. J., Liu, Q.-R., Gardner, E. L., Bonci, A., & Xi, Z.-X. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0037-3 · Cited by 54
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Bernal‐Chico, A., Tepavčević, V., Manterola, A., Utrilla, C. L., Matute, C., & Mato, S. (2022) · Glia · doi:10.1002/glia.24172 · Cited by 54
Potential neurotoxic activity of diverse molecules released by microglia
Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105117 · Cited by 53
Pan, L., Cho, K.-S., Wei, X., Xu, F., Lennikov, A., Hu, G., Tang, J., Guo, S., Chen, J., Kriukov, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112889 · Cited by 52
Penney, J., Ralvenius, W. T., Loon, A., Cerit, O., Dileep, V., Milo, B., Pao, P., Woolf, H., & Tsai, L. (2024) · Glia · doi:10.1002/glia.24485 · Cited by 52
Li, Q., Shen, C., Liu, Z., Ma, Y., Wang, J., Dong, H., Zhang, X., Wang, Z., Yu, M., Ci, L., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13094 · Cited by 51
Hohsfield, L. A., Najafi, A. R., Ghorbanian, Y., Soni, N., Crapser, J. D., Velez, D. X. F., Jiang, S., Royer, S. E., Kim, S. J., Henningfield, C. M., et al. (2021) · eLife · doi:10.7554/elife.66738 · Cited by 50
Rocha, S. M., Kirkley, K. S., Chatterjee, D., Aboellail, T., Smeyne, R. J., & Tjalkens, R. B. (2023) · Glia · doi:10.1002/glia.24385 · Cited by 49
Espadas, I., Keifman, E., Palomo‐Garo, C., Burgaz, S., García, C., Fernández‐Ruíz, J., & Moratalla, R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104892 · Cited by 48
Jayant, S., Sharma, B. M., Bansal, R., & Sharma, B. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.11.006 · Cited by 47
Yu, H., Liu, X., Chen, B., Vickstrom, C. R., Friedman, V., Kelly, T. J., Bai, X., Zhao, L., Hillard, C. J., & Liu, Q.-S. (2021) · Cells · doi:10.3390/cells10123548 · Cited by 47
Microglial Cannabinoid CB2 Receptors in Pain Modulation
Xu, K., Wu, Y., Tian, Z., Xu, Y., Wu, C., & Wang, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032348 · Cited by 47
A CB2-Selective cannabinoid suppresses T-Cell activities and increases tregs and IL-10
Robinson, R. H., Meissler, J. J., Fan, X., Yu, D., Adler, M. W., & Eisenstein, T. K. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9611-3 · Cited by 46
Zhou, R., Chen, S., Zhao, Z., Tu, D., Song, S., Wang, Y., Wang, Q., Feng, J., & Hong, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03393-w · Cited by 46
Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation
van den Hoogen, N. J., Harding, E. K., Davidson, C. E. D., & Trang, T. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.816747 · Cited by 45
Ruiz de Martín Esteban, S., Benito-Cuesta, I., Terradillos, I., Martínez-Relimpio, A. M., Arnanz, M. A., Ruiz-Pérez, G., Korn, C., Raposo, C., Sarott, R. C., Westphal, M. V., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841766 · Cited by 45
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44 · cited 1×
“…et al., 2023; Kitchener, Dundee, and Brown, 2023), in vitro (Zhou et al., 2023; Salvadores et al., 2022; C. Zhang et al., 2023), and genetic studies (Takatori et al., 2019; Andersen et al., 2021; Corley et al., 2021; ConsortiumInternational Multiple Sclerosis Genetics, 2019; Rodero et al., 2008).”
Sobue, A., Komine, O., Endo, F., Kakimi, C., Miyoshi, Y., Kawade, N., Watanabe, S., Saito, Y., Murayama, S., Saido, T. C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07249-6 · Cited by 42
Kaminski, N. E. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00284-7 · Cited by 38
Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia
Rentsch, P., Stayte, S., Egan, T., Clark, I., & Vissel, B. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104646 · Cited by 37
Self-citationRecent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
Gasperi, V., Guzzo, T., Topai, A., Gambacorta, N., Ciriaco, F., Nicolotti, O., & Maccarrone, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220825161603 · Cited by 37
Lu, J., Hou, L., Zhang, D., Li, S., Ruan, Z., Zhang, X., Hong, J., & Wang, Q. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s299927 · Cited by 34
Cannabinoid Receptors in Metabolic Regulation and Diabetes
Rohbeck, E., Eckel, J., & Romacho, T. (2021) · Physiology · doi:10.1152/physiol.00029.2020 · Cited by 33
Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis
Mader, M. M.-D., Napole, A., Wu, D., Atkins, M., Scavetti, A., Shibuya, Y., Foltz, A. G., Hahn, O., Yoo, Y., Danziger, R., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01609-3 · Cited by 32
Update on the controversial identity of cells expressing cnr2 gene in the nervous system
Grabon, W., Bodennec, J., Rheims, S., Belmeguenaï, A., & Bezin, L. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13977 · Cited by 28
Neurotoxic microglial activation via IFNγ-Induced Nrf2 reduction exacerbating alzheimer's disease
Kang, Y. J., Hyeon, S. J., McQuade, A., Lim, J., Baek, S. H., Diep, Y. N., Do, K. V., Jeon, Y., Jo, D., Lee, C. J., et al. (2024) · Advanced Science · doi:10.1002/advs.202304357 · Cited by 27
Piano, I., Votta, A., Colucci, P., Corsi, F., Vitolo, S., Cerri, C., Puppi, D., Lai, M., Maya‐Vetencourt, J. F., Leigheb, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47540-8 · Cited by 24
Deletion of muscarinic acetylcholine receptor 3 in microglia impacts brain ischemic injury
Costa, A., Haage, V., Yang, S., Wegner, S., Ersoy, B., Ugursu, B., Rex, A., Kronenberg, G., Gertz, K., Endres, M., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.09.008 · Cited by 23
Corley, E., Holleran, L., Fahey, L., Corvin, A. P., Morris, D. W., & Donohoe, G. J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01616-z · Cited by 22
Liu, X., Yu, H., Chen, B., Friedman, V., Mu, L., Kelly, T. J., Ruiz‐Pérez, G., Zhao, L., Bai, X., Hillard, C. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10081776 · Cited by 21
Wang, M., Liu, M., & Ma, Z. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08395-4 · Cited by 21
Gambacorta, N., Gasperi, V., Guzzo, T., Leva, F. S. D., Ciriaco, F., Sánchez, C., Tullio, V., Rozzi, D., Marinelli, L., Topai, A., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115647 · Cited by 21
More, S. A., Deore, R., Pawar, H. D., Sharma, C., Nakhate, K. T., Rathod, S., Ojha, S. K., & Goyal, S. N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031683 · Cited by 21
JWH133 inhibits MPP+-Induced inflammatory response and iron influx in astrocytes
Jia, Y., Deng, H., Qin, Q., & Ma, Z. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134779 · Cited by 18
Alenabi, A., & Malekinejad, H. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04158-6 · Cited by 17
Syk inhibitors protect against microglia-mediated neuronal loss in culture
Birkle, T. J. Y., & Brown, G. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1120952 · Cited by 17
Liang, S.-Q., Li, P.-H., Hu, Y., Zhao, J., Shao, F.-Z., Kuang, F., Ren, K., Wei, T., Fan, F., Feng, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193081 · Cited by 17
Joers, V. L., Murray, B. C., McLaughlin, C., Oliver, D. L., Staley, H. A., Coronado, J., Achat‐Mendes, C., Golshani, S., Kelly, S. D., Goodson, M. C., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03221-5 · Cited by 17
Finding the right tool: a comprehensive evaluation of microglial inducible cre mouse models
Bedolla, A., Mckinsey, G., Ware, K., Santander, N., Arnold, T., & Luo, Y. (2023) · doi:10.1101/2023.04.17.536878 · Cited by 17
Jang, J., Hong, A., Chung, Y. C., & Jin, B.-K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010571 · Cited by 16
Ferranti, A. S., & Foster, D. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.925792 · Cited by 15
Editorial: Therapeutic potential of the cannabinoid CB2 receptor
Smoum, R., Grether, U., Karsak, M., Vernall, A. J., Park, F., Hillard, C. J., & Pacher, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1039564 · Cited by 15
Nan, J., Liu, J., Lin, G., Zhang, S., Xia, A., Zhou, P., Zhou, Y., Zhang, J., Zhao, J., Zhang, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01943 · Cited by 14
Role of spindle pole body component 25 in neurodegeneration
Cui, F., Xu, Z., Lv, Y., & Hu, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4064 · Cited by 12
Activated microglia release β−galactosidase that promotes inflammatory neurodegeneration
Kitchener, E. J. A., Dundee, J. M., & Brown, G. C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1327756 · Cited by 12
Chen, S., Li, Z., Liu, Y., Xu, Z., Liu, A., He, Q., Xiao, F., & Zhan, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04836-2 · Cited by 12
Pathogenic Microglia Orchestrate Neurotoxic Properties of Eomes-Expressing Helper T Cells
Zhang, C., Raveney, B. J. E., Takahashi, F., Yeh, T.-W., Hohjoh, H., Yamamura, T., & Oki, S. (2023) · Cells · doi:10.3390/cells12060868 · Cited by 10
Loss of homeostatic functions in microglia from a murine model of Friedreich's ataxia
Valle, I. D., Milani, M., Rossi, S., Turchi, R., Tortolici, F., Nesci, V., Ferri, A., Valle, C., Lettieri‐Barbato, D., Aquilano, K., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101178 · Cited by 9
Rorato, R. C., Ferreira, N. L., de Oliveira, F. P., Fideles, H. J., Camilo, T. A., Antunes‐Rodrigues, J., Mecawi, A. S., & Elias, L. L. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105527 · Cited by 8
Yang, Y., Mou, B., Zhang, Q., Zhao, H., Zhang, J., Yun, X. Y., Xiong, M., Liu, Y., Liu, Y., Pan, H., et al. (2022) · Glia · doi:10.1002/glia.24438 · Cited by 8
Kong, W., Xie, Z., Shang, X.-K., Hayashi, Y., Lan, F., Narengaowa, Zhao, S., Li, H., Quan, Z., Wu, Z., et al. (2023) · Glia · doi:10.1002/glia.24447 · Cited by 5
Cannabinoid CB2 receptors enhance high-fat diet evoked peripheral neuroinflammation
Hosoki, H., Asahi, T., & Nozaki, C. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123002 · Cited by 5
Monory, K., & Lutz, B. (2005) · Nature Medicine · doi:10.1038/nm0405-378 · Cited by 1
Cited by
Moliterni, C., Caissutti, D., Mandolini, E., Fasciolo, E., Çağlar, T. R., Capozzi, A., Misasi, R., & Candelise, N. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1882543 · Cited by 1
Peralta, J. J. A., Fernández, A. M. M., & López, J. F. M. (2026) · Zaguan (University of Zaragoza Repository)
dos Santos, B. C., da Rosa, I. V., MAZZARDO, L. D. F., Santos, N. D. S., Fabro, I. F., Nery, T., Bastos-Pereira, A. L., & Aguiar, A. S. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00206
Metadata
- Authors
- Laloli, K. J., Rentsch, P., Stayte, S., & Vissel, B.
- Affiliations
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- Corresponding author
- Vissel, Bryce
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2025-11-19
- Volume
- 16
- Pages
- 1682979-1682979
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC12672438
- OpenAlex
- W4416403131
- Cited by
- 3
- References
- 159
- Citations by year
- 2026: 3
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Australian Government
- University of New South Wales
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- CB2 receptor, CNR2, floxed allele, microglia, tamoxifen-inducible Cre, CX3CR1, TMEM119, off-target effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.